Bal Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

15.92

15.80

15.69

14.82

14.82

Share application money

-

-

1.39

0.94

0.94

Preference share capital

-

-

-

-

-

Reserves & surplus

82.90

89.78

78.95

71.56

63.56

Loan funds

Secured loans

144.61

133.83

125.23

98.01

98.98

Unsecured loans

-

-

-

-

-

Total

243.44

239.41

221.26

185.33

178.30

Uses of funds

Fixed assets

Gross block

138.53

102.46

95.80

82.79

78.29

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

51.75

37.90

32.73

29.89

25.64

Net block

86.77

64.56

63.07

52.90

52.65

Capital work-in-progress

2.79

0.47

-

1.16

-

Investments

4.63

16.33

8.40

8.40

8.40

Net current assets

Current assets, loans & advances

256.38

279.94

276.24

227.16

200.49

Less : current liabilities & provisions

107.13

121.89

126.44

104.29

83.24

Total net current assets

149.25

158.05

149.80

122.87

117.25

Miscellaneous expenses not written

-

-

-

-

-

Total

243.44

239.41

221.26

185.33

178.30

Notes:

Book value of unquoted investments

2.16

9.59

-

-

9.57

Market value of quoted investments

2.47

0.11

-

-

-

Contingent liabilities

17.10

16.96

16.44

16.25

4.34

Number of equity sharesoutstanding (Lacs)

159.21

158.04

156.90

148.22

148.22